Frozen nerves to fight surgery pain? trial pulled before it began
NCT ID NCT05255146
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if freezing certain nerves during minimally invasive heart surgery could lower pain afterward. It planned to enroll adults having mitral valve or atrial septal defect repair. However, the trial was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Nitrous oxide cryoprobe (device that freezes nerves to block pain)
- What this could lead to
- If it worked, this could offer a way to reduce chronic pain after minimally invasive heart surgery.
- What could go wrong
- The trial was withdrawn before starting, so no results are available. The approach is still experimental and may not prove effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients aged 18 years or older scheduled for elective minimally invasive mitral valve surgery or atrial septal defect repair. Exclusion Criteria: * Patients will be excluded if they are unable to fill in detailed health and pain related questionnaires, psychiatric disease preventing recall or accurate descriptions of pain, chronic pain syndromes, alcohol or illegal substance abuse, or pregnancy. Exclusion criteria also includes chronic use of opioids, allergy to morphine, bupivacaine, and/or ibuprofen, average pain during the last week \>4 on a numerical rating scale from 0 to 10 with 0 indicating "no pain" and 10 indicating "the worst pain imaginable", contraindications to thoracic epidurals, prior chest surgery, or participation in another clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrial septal defect are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Analgesic requirement for Post-Operative pain control in elective 1-3 level transforaminal lumbar interbody fusion: comparison of thoracolumbar interfascial plane block with exparel to bupivacaine HCl
- Could a simple mineral calm the Body's Post-Surgery fire?
- Nanoparticle cleaning may calm pain after failed root canals in diabetic patients
- One pill before surgery may cut opioid use and improve sleep
- Can a tiny implant fix a leaky heart valve without open surgery?
- Can a Two-Drug anesthetic mix ease pain and cut narcotic use after heart device surgery?